Results 141 to 150 of about 60,209 (283)
American Journal of Hematology, Volume 100, Issue 5, Page 909-912, May 2025.
Marcos de Lima+14 more
wiley +1 more source
ABSTRACT BK polyomavirus (BKPyV) poses a significant threat to kidney transplant recipients (KTR). Current management primarily involves reducing immunosuppression, which increases the risk of rejection. Cell‐based immunotherapy with virus‐specific T cells (VST) has emerged as an alternative approach for treating BKPyV in KTRs. This single‐center phase
Lucy Ptak+8 more
wiley +1 more source
SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION
Carl G. Groth+12 more
openalex +1 more source
Cutaneous manifestations of Fabry disease: A systematic review
Abstract Fabry disease (FD) is a rare X‐linked lysosomal storage disorder resulting in potential debilitating accumulation of glycosphingolipids in organs such as skin, nerves, heart, kidneys, lungs, and the central nervous system. Skin is easily investigated and can guide clinicians to diagnose FD, minimizing delay of enzyme substitution therapy. This
Rami Nabil Al‐Chaer+4 more
wiley +1 more source
Rapidly progressive post-transplant lymphoproliferative disease following withdrawal of sirolimus [PDF]
Sirolimus, a potent inhibitor of B- and T-cell activation, is a commonly used immunosuppressant after renal transplantation. Withdrawal of sirolimus from the immunosuppression regimen may reduce B-cell surveillance.
Barday, Z+6 more
core +1 more source
In this study, we collected real‐world evidence on the use of pegcetacoplan among 22 Italian patients with paroxysmal nocturnal haemoglobinuria showing suboptimal response to anti‐C5 treatments eculizumab and ravulizumab. Most patients exhibited a complete or good response as per the criteria of the European Bone Marrow Transplant group (Risitano et al.
Elisabetta Metafuni+19 more
wiley +1 more source
CASE REPORT-SIROLIMUS RESCUE THERAPY FOR REFRACTORY RENAL ALLOGRAFT REJECTION1
Joel W. Slaton, Barry D. Kahan
openalex +1 more source
ABSTRACT Background and Aim Liver transplant (LT) recipients may succumb to graft‐related pathologies, contributing to graft fibrosis (GF). Current methods to diagnose GF are limited, ranging from procedural‐related complications to low accuracy. With recent advances in machine learning (ML), we aimed to develop a noninvasive tool using demographic ...
Madhumitha Rabindranath+3 more
wiley +1 more source